作者:Jacques Dumas、Holia Hatoum-Mokdad、Robert Sibley、Bernd Riedl、William J Scott、Mary Katherine Monahan、Timothy B Lowinger、Catherine Brennan、Reina Natero、Tiffany Turner、Jeffrey S Johnson、Robert Schoenleber、Ajay Bhargava、Scott M Wilhelm、Timothy J Housley、Gerald E Ranges、Alka Shrikhande
DOI:10.1016/s0960-894x(00)00272-9
日期:2000.9
Inhibitors of the MAP kinase p38 are potentially useful for the treatment of arthritis and osteoporosis. Several 2,3-dichlorophenyl ureas were identified as small-molecule inhibitors of p38 by a combinatorial chemistry effort. Optimization for cellular potency led to the discovery of a new class of potent and selective p38 kinase inhibitors, exemplified by the 1-phenyl-5-pyrazolyl urea 7 (IC50 = 13 nM). (C) 2000 Elsevier Science Ltd. All rights reserved.